M. Smith

Skeletal-related events and clinical outcomes in patients with bone metastases and normal levels of osteolysis: exploratory analyses.

J. Body, R. Cook, R. Coleman, 2013, Clinical oncology (Royal College of Radiologists (Great Britain)).

Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis

S. Devlin, S. Giralt, R. Comenzo, 2016, Leukemia.

Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.

J. Finkelstein, B. Leder, M. Fallon, 2001, The Journal of clinical endocrinology and metabolism.

Improvements in renal osteodystrophy in patients treated with lanthanum carbonate for two years.

H. Malluche, C. Swanepoel, M. Monier‐Faugere, 2008, Clinical nephrology.

A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

J. Paul, T. Evans, M. Soukop, 2000, British Journal of Cancer.

Phase II multicenter study of abiraterone acetate (AA) plus prednisone therapy in docetaxel-treated castration-resistant prostate cancer (CRPC) patients (pts): Impact of prior ketoconazole (keto).

H. Scher, G. Bubley, D. Danila, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of weekly nanoparticle paclitaxel (ABI-007), carboplatin and trastuzumab as first-line therapy of HER2-positive metastatic breast cancer.

D. Lake, C. Hudis, M. Robson, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Marked improvement in glycaemic control in a type 2 diabetes patient following a liver transplant for cirrhotic steatohepatitis

V. Parker, M. Smith, 2009 .

A first-in-human phase I clinical trial of CXR1002 in patients (pts) with advanced cancer.

D. Bissett, C. Wolf, A. Barnett, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response to nutritional and growth hormone treatment in progeria.

W. Brown, J. Abdenur, F. Lifshitz, 1997, Metabolism: clinical and experimental.

A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

T. Evans, M. Soukop, M. Eatock, 2000, British Journal of Cancer.